Skip to main content
. 2011 Aug 23;20(8):1639–1647. doi: 10.1007/s00520-011-1254-1

Fig. 2.

Fig. 2

Failure-free treatment duration and overall survival in patients who reached adequate pain control on parenteral hydromorphone (n = 86). Overall survival was calculated from the start of hydromorphone until death or end of the study (black dotted line); duration of hydromorphone use (grey dashed line). Failure-free survival was defined as the period from the start of hydromorphone until death or the application of more invasive techniques (light grey line)